Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 142

    1.

    Effects of celecoxib in human retinoblastoma cell lines and in a transgenic murine model of retinoblastoma.

    Tong CT, Howard SA, Shah HR, Van Quill KR, Lin ET, Grossniklaus HE, O'Brien JM.

    Br J Ophthalmol. 2005 Sep;89(9):1217-20.PMID: 16113385 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma.

    Tsui JY, Dalgard C, Van Quill KR, Lee L, Grossniklaus HE, Edelhauser HF, O'Brien JM.

    Invest Ophthalmol Vis Sci. 2008 Feb;49(2):490-6.PMID: 18234990 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma.

    Van Quill KR, Dioguardi PK, Tong CT, Gilbert JA, Aaberg TM Jr, Grossniklaus HE, Edelhauser HF, O'Brien JM.

    Ophthalmology. 2005 Jun;112(6):1151-8.PMID: 15885791 [PubMed - indexed for MEDLINE]Related articles

    4.

    Toxicity and dose-response studies of 1-alpha hydroxyvitamin D2 in LH-beta-tag transgenic mice.

    Dawson DG, Gleiser J, Zimbric ML, Darjatmoko SR, Lindstrom MJ, Strugnell SA, Albert DM.

    Ophthalmology. 2003 Apr;110(4):835-9.PMID: 12689912 [PubMed - indexed for MEDLINE]Related articles

    5.

    Paclitaxel in the treatment of retinal tumors of LH beta-Tag murine transgenic model of retinoblastoma.

    Suárez F, Jockovich ME, Hernandez E, Feuer W, Parel JM, Murray TG.

    Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3437-40.PMID: 17652710 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.

    Wang L, Chen W, Xie X, He Y, Bai X.

    Exp Oncol. 2008 Mar;30(1):42-51.PMID: 18438340 [PubMed - indexed for MEDLINE]Related articles

    7.

    Toxicity and dose-response studies of 1 alpha-hydroxyvitamin D2 in LH beta-Tag transgenic mice.

    Dawson DG, Gleiser J, Zimbric ML, Darjatmoko SR, Frisbie JC, Lokken JM, Lindstrom MJ, Audo I, Strugnell SA, Albert DM.

    Trans Am Ophthalmol Soc. 2002;100:125-9.PMID: 12545685 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Subconjunctival nanoparticle carboplatin in the treatment of murine retinoblastoma.

    Kang SJ, Durairaj C, Kompella UB, O'Brien JM, Grossniklaus HE.

    Arch Ophthalmol. 2009 Aug;127(8):1043-7.PMID: 19667343 [PubMed - indexed for MEDLINE]Related articles

    9.

    Basic fibroblast growth factor impact on retinoblastoma progression and survival.

    Cebulla CM, Jockovich ME, Piña Y, Boutrid H, Alegret A, Kulak A, Hackam AS, Bhattacharya SK, Feuer WJ, Murray TG.

    Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5215-21. Epub 2008 Jul 9.PMID: 18614803 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effectiveness of vitamin D analogues in treating large tumors and during prolonged use in murine retinoblastoma models.

    Albert DM, Kumar A, Strugnell SA, Darjatmoko SR, Lokken JM, Lindstrom MJ, Patel S.

    Arch Ophthalmol. 2004 Sep;122(9):1357-62.PMID: 15364716 [PubMed - indexed for MEDLINE]Related articles

    11.

    Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma.

    Dalgard CL, Van Quill KR, O'Brien JM.

    Clin Cancer Res. 2008 May 15;14(10):3113-23.PMID: 18483379 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Antitumoral action of the neurokinin-1-receptor antagonist L-733,060 and mitogenic action of substance P on human retinoblastoma cell lines.

    Muñoz M, Rosso M, Pérez A, Coveñas R, Rosso R, Zamarriego C, Soult JA, Montero I.

    Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2567-70.PMID: 15980249 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells.

    Cui W, Yu CH, Hu KQ.

    Clin Cancer Res. 2005 Nov 15;11(22):8213-21.PMID: 16299255 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Retinoblastoma tumor vessel maturation impacts efficacy of vessel targeting in the LH(BETA)T(AG) mouse model.

    Jockovich ME, Bajenaru ML, Piña Y, Suarez F, Feuer W, Fini ME, Murray TG.

    Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2476-82.PMID: 17525173 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Beta-lapachone inhibits proliferation and induces apoptosis in retinoblastoma cell lines.

    Shah HR, Conway RM, Van Quill KR, Madigan MC, Howard SA, Qi J, Weinberg V, O'Brien JM.

    Eye (Lond). 2008 Mar;22(3):454-60. Epub 2007 Mar 16.PMID: 17363928 [PubMed - indexed for MEDLINE]Related articles

    16.

    Phenoxazine derivative, 2-amino-4,4alpha-dihydro-4alpha,7-dimethyl-3H-phenoxazine-3-one suppresses growth of human retinoblastoma cell line Y79 in vitro and in vivo.

    Kimura K, Usui Y, Hattori T, Yamakawa N, Goto H, Usui M, Okada S, Shirato K, Tomoda A.

    Oncol Rep. 2008 Jan;19(1):3-10.PMID: 18097569 [PubMed - indexed for MEDLINE]Related articles

    17.

    Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model.

    Jockovich ME, Suarez F, Alegret A, Piña Y, Hayden B, Cebulla C, Feuer W, Murray TG.

    Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5371-6.PMID: 18055783 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Inhibitory effect of bevacizumab on the angiogenesis and growth of retinoblastoma.

    Lee SY, Kim DK, Cho JH, Koh JY, Yoon YH.

    Arch Ophthalmol. 2008 Jul;126(7):953-8.PMID: 18625942 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia.

    Farooqui M, Li Y, Rogers T, Poonawala T, Griffin RJ, Song CW, Gupta K.

    Br J Cancer. 2007 Dec 3;97(11):1523-31. Epub 2007 Oct 30.PMID: 17971769 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Evaluation of cyclooxygenase-2 inhibition in an orthotopic murine model of lung cancer for dose-dependent effect.

    Sievers EM, Bart RD, Backhus LM, Lin Y, Starnes M, Castanos R, Starnes VA, Bremner RM.

    J Thorac Cardiovasc Surg. 2005 Jun;129(6):1242-9.PMID: 15942563 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data